Schrödinger (Columbia) announces new equity investment

Schrödinger, a Columbia University spinoff focusing on chemical simulations for research in the pharmaceutical and biotechnology industries, announced on Tuesday, April 27, an equity investment from Cascade Investment, L.L.C. The investment will allow Schrodinger to make improvements in its computer-aided drug design. Cascade Investment is wholly owned by William H. Gates III.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: